SCHEMBL646642

SCHEMBL646642

CN(Cc1ccccc1Cl)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.52
RORC P51449 2/20 0.36
KEAP1 Q14145 6/20 0.35
NFE2L2 Q16236 6/20 0.35
HSP90AB1 P08238 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
KCNJ6 P48051 1/20 0.33
KCNJ5 P48544 1/20 0.33
KCNJ3 P48549 1/20 0.33
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL646377 0.94 HSP90AA1 (0.47) HSP90AA1RORCKEAP1NFE2L2HSP90AB1
SCHEMBL644848 0.94 HSP90AA1 (0.52) HSP90AA1RORCKEAP1NFE2L2ALDH1A1
SCHEMBL645274 0.93 HSP90AA1 (0.49) HSP90AA1RORCKEAP1NFE2L2ALDH1A1
SCHEMBL646699 0.92 HSP90AA1 (0.49) HSP90AA1KEAP1NFE2L2HSP90AB1ALDH1A1
SCHEMBL646966 0.90 HSP90AA1 (0.52) HSP90AA1HSP90AB1ALDH1A1LMNAPOLB
SCHEMBL4933407 0.89 HSP90AA1 (0.55) HSP90AA1ALDH1A1LMNASMN1; SMN2
SCHEMBL644577 0.89 HSP90AA1 (0.46) HSP90AA1HSP90AB1ALDH1A1LMNASMN1; SMN2
SCHEMBL646667 0.89 HSP90AA1 (0.51) HSP90AA1HSP90AB1ALDH1A1LMNAPOLB
SCHEMBL644660 0.89 HSP90AA1 (0.47) HSP90AA1HSP90AB1ALDH1A1LMNAPOLB
SCHEMBL645309 0.88 HSP90AA1 (0.47) HSP90AA1KEAP1NFE2L2HSP90AB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885RORC 749/4885KEAP1 1083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.